Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease

NCT06832839 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2025-02-18

No results posted yet for this study

Summary

The purpose of this study is to comprehensively evaluate the risk factors for cognitive decline in patients with moyamoya disease, identify imaging target areas associated with cognitive damage in the brain, and explore the changes in brain structure and functional networks resulting from cerebral revascularization, as well as their relationship with cognitive improvement.

Conditions

  • Moyamoya Disease

Interventions

PROCEDURE

Revascularization

Revascularization

Sponsors & Collaborators

  • Beijing Tiantan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-16
Primary Completion
2025-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06832839 on ClinicalTrials.gov